MFN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.837600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.534400E-01
Normal-vs-Stage2
8.616600E-01
Normal-vs-Stage3
3.937500E-02
Normal-vs-Stage4
4.883200E-01
Stage1-vs-Stage2
6.271200E-01
Stage1-vs-Stage3
9.540300E-02
Stage1-vs-Stage4
1.900200E-01
Stage2-vs-Stage3
4.572100E-02
Stage2-vs-Stage4
3.323400E-01
Stage3-vs-Stage4
1.736280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.463400E-01
Normal-vs-AfricanAmerican
5.640200E-01
Normal-vs-Asian
7.756200E-01
Caucasian-vs-AfricanAmerican
1.908180E-01
Caucasian-vs-Asian
8.971000E-01
AfricanAmerican-vs-Asian
3.454600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.294800E-01
Normal-vs-Female
8.625600E-01
Male-vs-Female
5.714800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.751200E-01
Normal-vs-Age(41-60Yrs)
7.972400E-01
Normal-vs-Age(61-80Yrs)
6.568200E-01
Normal-vs-Age(81-100Yrs)
4.211800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.014400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.043800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.946800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.450030E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.419700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.227000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.469800E-01
Normal-vs-Daily Drinker
7.360000E-01
Normal-vs-Weekly Drinker
8.329000E-01
Normal-vs-Occasional Drinker
7.510000E-01
Normal-vs-Social Drinker
9.581600E-01
Non Drinker-vs-Daily Drinker
7.528400E-02
Non Drinker-vs-Weekly Drinker
1.755800E-01
Non Drinker-vs-Occasional Drinker
4.701600E-03
Non Drinker-vs-Social Drinker
5.382400E-02
Daily Drinker-vs-Weekly Drinker
9.757200E-01
Daily Drinker-vs-Occasional Drinker
2.167600E-01
Daily Drinker-vs-Social Drinker
5.482000E-01
Weekly Drinker-vs-Occasional Drinker
3.844400E-01
Weekly Drinker-vs-Social Drinker
6.730200E-01
Occasional Drinker-vs-Social Drinker
7.352200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.565800E-01
Normal-vs-Grade 2
9.806800E-01
Normal-vs-Grade 3
9.924000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.484200E-01
Grade 1-vs-Grade 3
5.443800E-01
Grade 1-vs-Grade 4
9.565800E-01
Grade 2-vs-Grade 3
4.428400E-01
Grade 2-vs-Grade 4
9.806800E-01
Grade 3-vs-Grade 4
9.924000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.988200E-01
Normal-vs-NonDiabetic
6.982800E-01
Diabetic-vs-NonDiabetic
8.300200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.279400E-01
Normal-vs-NoPancreatitis
7.076400E-01
Pancreatitis-vs-NoPancreatitis
5.112800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.666800E-01
Normal-vs-N1
8.113600E-01
N0-vs-N1
6.904400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.844000E-01
Normal-vs-TP53-NonMutant
6.781200E-01
TP53-Mutant-vs-TP53-NonMutant
5.814100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
